Dataset Information

Cholesterol Homeostasis Disruption and Monocyte Recruitment Drive Atrial Fibrillation in Hypertension

ABSTRACT: ABSTRACT BACKGROUND: Atrial fibrillation (AF) is the most common cardiac arrhythmia, with hypertension as its primary risk factor. While immune dysfunction is known to play a crucial role in hypertension, its specific impact on AF in the hypertensive setting remains underexplored. This study aims to elucidate the immune landscape of AF in the context of hypertension and explore the potential mechanisms. METHODS: Single-cell RNA transcriptomic analysis was employed to profile peripheral blood mononuclear cells (PBMCs) in hypertensive patients with AF, using hypertensive patients without AF as controls. Flow cytometry, serum cytokine analysis, and cohort studies were used for validation. RESULTS: Monocytes were identified as the most significantly affected cell type in hypertensive patients with AF, showing heightened disruption of cholesterol homeostasis and immune-inflammatory responses. Interestingly, a unique cluster of CD14+ megakaryocytes were identified to exhibit the most active intercellular interactions. Flow cytometry confirmed elevated proportions of CD14+ monocytes and CD14+ megakaryocytes in hypertensive patients with AF. Serum analysis of a larger cohort revealed significantly higher levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6). Integration of single-cell data from blood and cardiac tissue confirmed enhanced monocyte recruitment and differentiation in hypertensive patients with AF. Cohort studies further supported that the increased number of circulating monocytes was associated with a higher incidence of AF in hypertensive patients. CONCLUSIONS: Our study demonstrated that the interplay between cholesterol homeostasis disruption and inflammatory cell recruitment may play an important role in the pathogenesis of AF in hypertension. These findings offer new insights into potential therapeutic targets for managing AF in hypertensive patients.

ORGANISM(S): Homo sapiens

PROVIDER: GSE285199 | GEO | 2025/12/31

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Rationale: Pulmonary arterial hypertension is a common and potentially fatal complication of scleroderma that may involve inflammatory and autoimmune mechanisms. Alterations in the gene expression of peripheral blood mononuclear cells have been previously described in patients with pulmonary arterial hypertension. The ability to identify patients at risk for developing pulmonary hypertension would be clinically beneficial. Objective: To identify genes that are differentially expressed in peripheral blood mononuclear cells in scleroderma patients with and without pulmonary hypertension which could be used as biomarkers of disease for early diagnosis and provide insight into pathogenesis of pulmonary hypertension in at-risk populations. Methods and Results: Gene expression analysis was performed on a carefully characterized Microarray Cohort of scleroderma patients with (n=10) and without (n=10) pulmonary hypertension. Differentially expressed genes were confirmed in the Microarray Cohort and validated in a separate Validation Cohort of scleroderma patients with (n=15) and without (n=19) pulmonary hypertension by RT-qPCR. We identified inflammatory and immune-related genes including interleukin-7 receptor (IL-7R) and chemokine receptor 7 (CCR7) as differentially expressed in patients with scleroderma-associated pulmonary hypertension. Flow cytometry confirmed decreased expression of IL-7R on circulating CD4+ T cells from scleroderma patients with pulmonary hypertension. Conclusions: Differences exist in the expression of inflammatory and immune-related genes in peripheral blood cells derived from patients with scleroderma-related pulmonary hypertension compared to those with normal pulmonary artery pressures. These findings may have implications as biomarkers to screen at-risk populations to facilitate early diagnosis and provide insight into inflammatory and autoimmune mechanisms of scleroderma-related pulmonary hypertension. Gene expression analysis was performed on a carefully characterized Microarray Cohort of scleroderma patients with (n=10) and without (n=10) pulmonary hypertension. Differentially expressed genes were confirmed in the Microarray Cohort by RT-qPCR.

Project description:BACKGROUND: SLE is a complex autoimmune disease with deleterious effects on various organs. Accumulating evidence has shown abnormal vitamin B12 and one-carbon flux contribute to immune dysfunction. Transcobalamin II (TCN2) belongs to the vitamin B12-binding protein family responsible for the cellular uptake of vitamin B12. The role of TCN2 in SLE is still unclear.METHODS: We collected clinical information and blood from 51 patients with SLE and 28 healthy controls. RNA sequencing analysis, qPCR and western blot confirmed the alteration of TCN2 in disease monocytes. The correlation between TCN2 expression and clinical features and serological abnormalities was analyzed. TCN2 heterozygous knockout THP1 cells were used to explore the effects of TCN2 dysfunction on monocytes. CCK-8 assay and EdU staining were used to detect cell proliferation. ELISA was conducted to assess vitamin B12, glutathione and cytokines changes. UHPLC-MRM-MS/MS was used to detect changes in the intermediates of the one-carbon cycle. Flow cytometry is used to detect cell cycle, ROS, mitoROS and CD14 changes.RESULTS: Elevated TCN2 in monocytes was correlated positively with disease progression and specific tissue injuries. Using CD14+ monocytes and TCN2 genetically modified THP1 cell lines, we found that the TCN2 was induced by LPS in serum from SLE patients. TCN2 heterozygous knockout inhibited cellular vitamin B12 uptake and one-carbon metabolism, leading to cell proliferation arrest and decreased Toll-like receptor 4 (TLR4)-mediated CCL2 release. Methionine cycle metabolites, s-adenosylmethionine and homocysteine, rescued these effects, whereas folate treatment proved to be ineffective. Folate deficiency also failed to replicate the impact of TCN2 downregulation on THP1 inflammatory response.CONCLUSION: Our study elucidated the unique involvement of TCN2-driven one-carbon flux on SLE-associated monocyte behavior. Increased TCN2 may promote disease progression and tissue damage by enhancing one-carbon flux, fostering monocyte proliferation and exacerbating TLR4 mediated inflammatory responses. The inhibition of TCN2 may be a promising therapeutic approach to ameliorate SLE.

Dataset Information

Cholesterol Homeostasis Disruption and Monocyte Recruitment Drive Atrial Fibrillation in Hypertension

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets